• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反式激活将多条途径与ERK/丝裂原活化蛋白激酶级联反应相连。

Transactivation joins multiple tracks to the ERK/MAPK cascade.

作者信息

Wetzker Reinhard, Böhmer Frank-D

机构信息

Institute for Molecular Cell Biology, Jena University Hospital, Drackendorfer Strasse 1, D-07747 JENA, Germany.

出版信息

Nat Rev Mol Cell Biol. 2003 Aug;4(8):651-7. doi: 10.1038/nrm1173.

DOI:10.1038/nrm1173
PMID:12923527
Abstract

Many agonists of G-protein-coupled receptors (GPCRs) can stimulate receptor tyrosine kinases and the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) pathway. A 'transactivation' mechanism, which links these events in one signalling chain, inspired many researchers, but inevitably raised new questions. A 'multi-track' model for GPCR signalling to the ERK/MAPK pathway might resolve some of the puzzles in the transactivation field.

摘要

许多G蛋白偶联受体(GPCRs)的激动剂能够刺激受体酪氨酸激酶以及细胞外信号调节激酶(ERK)/丝裂原活化蛋白激酶(MAPK)信号通路。一种将这些事件连接在一条信号链中的“转活化”机制启发了许多研究人员,但不可避免地也引发了新问题。一种关于GPCR向ERK/MAPK信号通路进行信号传导的“多途径”模型或许能够解决转活化领域中的一些谜题。

相似文献

1
Transactivation joins multiple tracks to the ERK/MAPK cascade.反式激活将多条途径与ERK/丝裂原活化蛋白激酶级联反应相连。
Nat Rev Mol Cell Biol. 2003 Aug;4(8):651-7. doi: 10.1038/nrm1173.
2
Multiple pathways of ERK activation by G protein-coupled receptors.G蛋白偶联受体激活ERK的多种途径。
Novartis Found Symp. 2001;239:68-79; discussion 80-4, 150-9. doi: 10.1002/0470846674.ch7.
3
Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.表皮生长因子受体反式激活在G蛋白偶联受体介导的丝裂原活化蛋白激酶磷酸肌醇3激酶依赖性激活中的作用
J Cell Physiol. 2006 Jan;206(1):47-57. doi: 10.1002/jcp.20423.
4
Epidermal-growth-factor receptor and metalloproteinases mediate thromboxane A2-dependent extracellular-signal-regulated kinase activation.表皮生长因子受体和金属蛋白酶介导血栓素A2依赖性细胞外信号调节激酶激活。
Biochem J. 2003 May 1;371(Pt 3):733-42. doi: 10.1042/BJ20021030.
5
Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.溶血磷脂酸诱导的鳞状细胞癌细胞增殖和迁移涉及表皮生长因子受体信号转活化。
Cancer Res. 2002 Nov 1;62(21):6329-36.
6
New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades.七螺旋受体向丝裂原活化蛋白激酶级联反应信号传导的新机制。
Oncogene. 2001 Mar 26;20(13):1532-9. doi: 10.1038/sj.onc.1204184.
7
Activation of B-Raf and regulation of the mitogen-activated protein kinase pathway by the G(o) alpha chain.G(o)α链对B-Raf的激活及丝裂原活化蛋白激酶途径的调控。
Mol Biol Cell. 2000 Apr;11(4):1129-42. doi: 10.1091/mbc.11.4.1129.
8
Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.内皮素-1诱导人卵巢癌细胞有丝分裂信号转导过程中表皮生长因子受体的反式激活
Cancer Res. 2000 Sep 15;60(18):5310-7.
9
Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation.介导促肾上腺皮质激素释放激素-R1α-丝裂原活化蛋白激酶(MAPK)相互作用的信号分子的鉴定:磷脂酰肌醇3-激酶在调节ERK1/2而非p38 MAPK激活中的关键作用。
Mol Endocrinol. 2006 Dec;20(12):3179-95. doi: 10.1210/me.2006-0255. Epub 2006 Sep 7.
10
Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling.μ阿片受体在星形胶质细胞中的反式激活及表皮生长因子受体的下调:对丝裂原活化蛋白激酶信号传导的影响
Mol Pharmacol. 2003 Dec;64(6):1391-401. doi: 10.1124/mol.64.6.1391.

引用本文的文献

1
FLT3 signaling inhibition abrogates opioid tolerance and hyperalgesia while preserving analgesia.FLT3 信号抑制可消除阿片耐受和痛觉过敏,同时保留镇痛作用。
Nat Commun. 2024 Nov 7;15(1):9633. doi: 10.1038/s41467-024-54054-y.
2
Photonanozyme-Kras-ribosome combination treatment of non-small cell lung cancer after COVID-19.光纳米酶-Kras-核糖体联合治疗 COVID-19 后的非小细胞肺癌。
Front Immunol. 2024 Sep 6;15:1420463. doi: 10.3389/fimmu.2024.1420463. eCollection 2024.
3
Pharmacological Treatments and Therapeutic Targets in Muscle Dystrophies Generated by Alterations in Dystrophin-Associated Proteins.
药物治疗和治疗靶点在肌肉营养不良症中的变化与肌营养不良蛋白相关蛋白。
Medicina (Kaunas). 2024 Jun 27;60(7):1060. doi: 10.3390/medicina60071060.
4
Impact of Interleukin-6 Activation and Arthritis on Epidermal Growth Factor Receptor (EGFR) Activation in Sensory Neurons and the Spinal Cord.白细胞介素-6 激活和关节炎对感觉神经元和脊髓中表皮生长因子受体 (EGFR) 激活的影响。
Int J Mol Sci. 2024 Jun 28;25(13):7168. doi: 10.3390/ijms25137168.
5
Targeting Tyro3, Axl, and MerTK Receptor Tyrosine Kinases Significantly Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibition.靶向酪氨酸激酶3、Axl和MerTK受体酪氨酸激酶可显著增强三阴性乳腺癌对CDK4/6抑制的敏感性。
Cancers (Basel). 2024 Jun 18;16(12):2253. doi: 10.3390/cancers16122253.
6
Dopamine transporter membrane mobility is bidirectionally regulated by phosphorylation and palmitoylation.多巴胺转运体膜流动性受磷酸化和棕榈酰化的双向调节。
Curr Res Physiol. 2023 Sep 29;6:100106. doi: 10.1016/j.crphys.2023.100106. eCollection 2023.
7
An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis.G蛋白偶联受体信号传导及其在胃癌发生中的失调研究进展
Cancers (Basel). 2023 Jan 25;15(3):736. doi: 10.3390/cancers15030736.
8
Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward.μ-阿片受体与受体酪氨酸激酶的相互作用:对阿片类药物耐受性、神经性疼痛镇痛效果降低、依赖性和奖赏机制的影响。
Front Syst Neurosci. 2022 Dec 1;16:1059089. doi: 10.3389/fnsys.2022.1059089. eCollection 2022.
9
Reducing brain TACE activity improves neuroinflammation and cardiac function in heart failure rats.降低心力衰竭大鼠大脑中的组织蛋白酶A活性可改善神经炎症和心脏功能。
Front Physiol. 2022 Nov 9;13:1052304. doi: 10.3389/fphys.2022.1052304. eCollection 2022.
10
Development of a novel cell-based, In-Cell Western/ERK assay system for the high-throughput screening of agonists acting on the delta-opioid receptor.开发一种新型的基于细胞的细胞内western/ERK检测系统,用于高通量筛选作用于δ-阿片受体的激动剂。
Front Pharmacol. 2022 Sep 26;13:933356. doi: 10.3389/fphar.2022.933356. eCollection 2022.